IFM Investors Pty Ltd bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 41,177 shares of the company's stock, valued at approximately $1,314,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. increased its position in Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock worth $334,029,000 after purchasing an additional 781,681 shares during the last quarter. Victory Capital Management Inc. increased its position in Bath & Body Works by 14,732.0% during the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after purchasing an additional 6,752,274 shares during the last quarter. Alliancebernstein L.P. increased its position in Bath & Body Works by 4.7% during the first quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after purchasing an additional 243,611 shares during the last quarter. AQR Capital Management LLC increased its position in Bath & Body Works by 267.8% during the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock worth $121,073,000 after purchasing an additional 2,907,506 shares during the last quarter. Finally, GMT Capital Corp increased its position in Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company's stock worth $113,327,000 after purchasing an additional 255,600 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Bath & Body Works Price Performance
Shares of NYSE BBWI traded up $0.65 during midday trading on Thursday, hitting $26.38. The company's stock had a trading volume of 2,884,481 shares, compared to its average volume of 5,341,600. The business's fifty day simple moving average is $29.89 and its two-hundred day simple moving average is $29.93. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The firm has a market capitalization of $5.44 billion, a price-to-earnings ratio of 7.81, a price-to-earnings-growth ratio of 0.89 and a beta of 1.49.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the firm posted $0.37 earnings per share. The business's revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.0%. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on BBWI shares. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Barclays raised their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Morgan Stanley dropped their price target on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a research report on Friday, September 12th. JPMorgan Chase & Co. lifted their price target on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Finally, Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a research report on Thursday, August 28th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.69.
Get Our Latest Research Report on BBWI
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.